Fibrate/Related Articles: Difference between revisions
< Fibrate
Jump to navigation
Jump to search
imported>Howard C. Berkowitz (New page: {{subpages}} {{TOC|right}} ==Parent topics== {{r|Dyslipidemia}} {{r|Antilipemic agent}} {{r|Peroxisome proliferator-activated receptor alpha}} ==Subtopics== {{r|Bezafibrate}} {{r|Clofenap...) |
(No difference)
|
Latest revision as of 14:39, 3 November 2009
- See also changes related to Fibrate, or pages that link to Fibrate or to this page or whose text contains "Fibrate".
Parent topics
- Dyslipidemia [r]: Abnormal lipid serum levels, such as high total cholesterol or triglycerides, low HDL or high LDL cholesterol. [e]
- Antilipemic agent [r]: Medications for the treatment of hypercholesterolemia and hypertriglyceridemia. [e]
- Peroxisome proliferator-activated receptor alpha [r]: Add brief definition or description
Subtopics
- Bezafibrate [r]: Add brief definition or description
- Clofenapate [r]: Add brief definition or description
- Clofibrate [r]: Fibric acid derivative used to treat hyperlipoproteinemia type III and severe hypertriglyceridemia. [e]
- Gemfibrozil [r]: A drug that lowers serum triglyceride levels, with variable effects on cholesterol. [e]
- Procetofen [r]: Add brief definition or description
- Thiazolidinedione [r]: Add brief definition or description
- Metabolic syndrome [r]: Clustering of medical conditions associated with abdominal obesity, hypertriglyceridemia, low level of high-density lipoproteins, hypertension, and high fasting glucose level. [e]
- Diabetes mellitus [r]: Relative or absolute lack of insulin leading to uncontrolled carbohydrate metabolism. [e]